Status:

COMPLETED

Grains Reduce Adiposity and Improve Nutrition Study

Lead Sponsor:

Penn State University

Collaborating Sponsors:

General Mills

Conditions:

Metabolic Syndrome

Insulin Resistance

Eligibility:

All Genders

35-55 years

Phase:

NA

Brief Summary

Whole grain intake beneficially affects body weight, body fat and glucose metabolism, and the investigators' previous work has shown that a high whole grain intake significantly reduced body fat in th...

Detailed Description

Including whole grains as part of a heart-healthy diet has been shown to be beneficial in decreasing body weight and body fat. The beneficial effects of whole grains on body weight may be explained by...

Eligibility Criteria

Inclusion

  • BMI \> 25 to \< 42
  • Waist circumference of \> 40 inches for males and \> 35 inches for females and having one other of the criteria for metabolic syndrome will be recruited
  • In this population, we will also accept the following:
  • LDL-C \< 175 mg/dL
  • HDL-C \> 25 mg/dL
  • Triglycerides \< 400 mg/dL
  • All subjects will be required to meet one specific criteria for metabolic syndrome beyond increased waist circumference

Exclusion

  • Smokers
  • Have insulin-dependent diabetes
  • Are pregnant or expecting to be pregnant, lactating in the last 6 months
  • Are taking NSAIDS or other medications known to affect inflammatory markers or drugs affecting glucose metabolism
  • Blood pressure lowering medications are acceptable if the person has controlled BP at screening, \<140/90 mmHg.

Key Trial Info

Start Date :

March 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2011

Estimated Enrollment :

54 Patients enrolled

Trial Details

Trial ID

NCT00924521

Start Date

March 1 2009

End Date

August 1 2011

Last Update

August 21 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Penn State University

University Park, Pennsylvania, United States, 16802